Q3 2025 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2025-11-14 · accession 0001420506-25-003410
$3.37B
Reported value
73
Positions
2025-09-30
Period end
The Brief · BRAIDWELL LP · Q3 2025
AI · grounded in 13F
BRAIDWELL LP established a new position in Guardant Health Inc [[stock:GH 1.25 02/15/31]] valued at $286.3M. The fund also initiated new stakes in Caris Life Sciences Inc CAI for $221.3M and Novocure Ltd [[stock:NVCR 0 11/01/25]] for $210M. Other new additions include Xenon Pharmaceuticals Inc XENE and CG Oncology Inc CGON.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAD1 | GH 1.25 02/15/31 | GUARDANT HEALTH INC | $286.3M | 8.49% | 219,454,000 | Common | SOLE |
| 142152107 | CAI | CARIS LIFE SCIENCES INC | $221.3M | 6.57% | 7,316,142 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $210.0M | 6.23% | 211,364,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $144.7M | 4.29% | 3,605,029 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $132.3M | 3.92% | 3,283,317 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $123.6M | 3.67% | 880,282 | Common | SOLE |
| 759916AD1 | RGEN 1 12/15/28 | REPLIGEN CORP | $101.8M | 3.02% | 101,000,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $91.9M | 2.73% | 520,401 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $87.6M | 2.60% | 1,012,982 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $86.8M | 2.58% | 100,381,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $86.7M | 2.57% | 1,281,989 | Common | SOLE |
| 450056AB2 | IRTC 1.5 09/01/29 | IRHYTHM TECHNOLOGIES INC | $85.4M | 2.53% | 62,000,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $84.5M | 2.51% | 5,210,831 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $72.9M | 2.16% | 82,140,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $65.6M | 1.95% | 883,747 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $63.6M | 1.89% | 780,164 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $61.3M | 1.82% | 309,339 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $59.6M | 1.77% | 1,826,155 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $58.2M | 1.73% | 130,227 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $57.2M | 1.70% | 1,438,745 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $56.1M | 1.67% | 76,091 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $55.3M | 1.64% | 113,933 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $51.3M | 1.52% | 409,691 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $50.8M | 1.51% | 2,378,655 | Common | SOLE |
| 433313103 | HNGE | HINGE HEALTH INC | $44.7M | 1.33% | 910,476 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $43.2M | 1.28% | 2,578,404 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $39.4M | 1.17% | 351,248 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $38.8M | 1.15% | 225,845 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $35.9M | 1.06% | 141,528 | Common | SOLE |
| 48576UAD8 | KPTI 6 05/13/29 * | KARYOPHARM THERAPEUTICS INC | $35.0M | 1.04% | 48,482,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $34.5M | 1.02% | 2,730,481 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $33.1M | 0.98% | 438,600 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $32.9M | 0.97% | 835,057 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $31.7M | 0.94% | 2,182,781 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $28.6M | 0.85% | 528,000 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $28.5M | 0.85% | 498,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $26.6M | 0.79% | 1,382,350 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $26.2M | 0.78% | 195,656 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $25.0M | 0.74% | 643,180 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $24.7M | 0.73% | 121,700 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $24.0M | 0.71% | 8,353,287 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $22.7M | 0.67% | 414,600 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $22.6M | 0.67% | 475,400 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $22.0M | 0.65% | 1,514,604 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $20.5M | 0.61% | 1,107,770 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $20.0M | 0.59% | 759,455 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $18.7M | 0.56% | 822,735 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $18.4M | 0.55% | 303,685 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $17.7M | 0.53% | 588,700 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $16.5M | 0.49% | 342,391 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $16.0M | 0.48% | 832,100 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $15.7M | 0.46% | 276,692 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $15.5M | 0.46% | 2,266,319 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $15.4M | 0.46% | 2,181,598 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $15.3M | 0.45% | 591,689 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $14.6M | 0.43% | 1,246,280 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $14.5M | 0.43% | 331,907 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $14.4M | 0.43% | 113,335 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $13.7M | 0.41% | 472,739 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $13.7M | 0.41% | 1,771,146 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $13.4M | 0.40% | 13,500,000 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $11.6M | 0.34% | 736,867 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $11.5M | 0.34% | 2,750,092 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $11.0M | 0.33% | 736,014 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $10.7M | 0.32% | 2,472,806 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $9.2M | 0.27% | 314,013 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $8.3M | 0.25% | 612,841 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $6.4M | 0.19% | 182,068 | Common | SOLE |
| 45258DAB1 | IMCR 2.5 02/01/30 | IMMUNOCORE HLDGS PLC | $6.2M | 0.18% | 6,828,000 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $2.0M | 0.06% | 219,488 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.8M | 0.05% | 140,000 | Common | SOLE |
| 42238D107 | HTFL | HEARTFLOW INC | $1.7M | 0.05% | 50,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $1.2M | 0.04% | 752,541 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.